메뉴 건너뛰기




Volumn 82, Issue 2, 2011, Pages 160-161

Efficacy of liraglutide in a patient with type 2 diabetes and cryptogenic cirrhosis

Author keywords

Cryptogenic cirrhosis; Liraglutide; Type 2 diabetes mellitus

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIRAGLUTIDE; METFORMIN; TRIACYLGLYCEROL; DRUG DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; INCRETIN;

EID: 84860555013     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (6)
  • 1
    • 34447571958 scopus 로고    scopus 로고
    • The multifaceted associations of hepa- tobiliary disease and diabetes
    • Bell DS, Allbright E. The multifaceted associations of hepa- tobiliary disease and diabetes. Endocr Pract 2007; 13 (3): 300-12.
    • (2007) Endocr Pract , vol.13 , Issue.3 , pp. 300-312
    • Bell, D.S.1    Allbright, E.2
  • 2
    • 78049354214 scopus 로고    scopus 로고
    • Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide
    • Flint A, Nazzal K, Jagielski P, Hindsberger C, Zdravkovic M. Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide. Br J Clin Pharmacol 2010; 70 (6): 807-14.
    • (2010) Br J Clin Pharmacol , vol.70 , Issue.6 , pp. 807-814
    • Flint, A.1    Nazzal, K.2    Jagielski, P.3    Hindsberger, C.4    Zdravkovic, M.5
  • 3
    • 77956193795 scopus 로고    scopus 로고
    • Abstracts of the 46th General Assem- bly of the European Association for the Study of Diabetes (EASD)
    • Stockholm, Sweden. September 20-24, 2010
    • Armstrong M, et al. Abstracts of the 46th General Assem- bly of the European Association for the Study of Diabetes (EASD). Stockholm, Sweden. September 20-24, 2010. Diabetologia 2010; 53 (Suppl 1): S7-533.
    • (2010) Diabetologia , vol.53 , Issue.SUPPL. 1
    • Armstrong, M.1
  • 4
    • 84860817470 scopus 로고    scopus 로고
    • ®
    • ®
  • 5
    • 79955777481 scopus 로고    scopus 로고
    • Liraglutide: Once-daily GLP-1 agonist for the treatment of type 2 diabetes
    • Jun
    • Ryan GJ, Hardy Y. Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes. J Clin Pharm Ther 2011 Jun;36(3):260-74.
    • (2011) J Clin Pharm Ther , vol.36 , Issue.3 , pp. 260-274
    • Ryan, G.J.1    Hardy, Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.